跳至主要内容
临床试验/JPRN-jRCT1031190025
JPRN-jRCT1031190025已完成4 期

Comparison study to evaluate the effect of denosumab or alendronate sodium hydrate on coronary artery calcification score for osteoporosis with complications of coronary artery disease

Kubota Naoki0 个研究点目标入组 1 人开始时间: 2019年5月20日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1

研究概览

简要总结

This study was suspended due to difficulty in securing the required number of patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients (>20 years old) with osteoporosis with coronary artery calcification

排除标准

  • Patients who can not enforce coronary artery CT, patients with baseline coronary calcification score of 0 or 1000 or more, secondary osteoporosis patients, patients with severe renal impairment(eGFR<35mL/min).

研究者

发起方
Kubota Naoki

相似试验

Efficacy of coronary artery calcification on... | 临床试验